Gillian Gittens, Director of eClinical Strategy and Solutions, is a TMF industry veteran with over 25 years’ experience. Gill has a wealth of insight and expertise in managing TMF services and delivering ongoing customer success across all aspects of TMF operations. A member of the CDISC TMF Reference Model Steering Committee and Project Management Team leading the V4 initiative, Gill has key expertise and insight in industry best practice, regulatory guidance and the future of TMF management.

Paul Dillon is a Real-World Evidence (RWE) Strategy Lead at UCB, where he develops evidence strategies to support drug development, market access, and innovation across immunology and emerging therapeutic areas. His work focuses on leveraging real-world data, advanced analytics, and AI-enabled approaches to generate actionable insights that inform clinical development and healthcare decision-making. Paul has led RWE strategies for multiple early- and late-stage programs, with particular expertise in integrating data science and AI into evidence generation. He is passionate about AI’s potential to transform how healthcare evidence is created and applied.

Nick Goelen, PhD, is a clinical research professional with 10 years of experience spanning bedside research, project management, and Phase I–III clinical development. His expertise includes gastroenterology, rare paediatric diseases, neurology, nutrition, and medical devices. Having helped build a MedTech start-up from the ground up, Nick understands the balance between speed, innovation, and the rigor required for successful clinical development. At 2 Bridge, he helps clients navigate operational challenges and accelerate progress while leading initiatives to explore the smart, efficient, and compliant use of AI in clinical development and day-to-day operations.

Michaela Dinboeck leads Novartis’ global Patient Engagement (PE) team, overseeing the strategy and implementation of patient-focused medicines development. Her team systematically embeds patient experience information throughout the medicine lifecycle, from early-stage development through regulatory submissions. Prior to leading PE, Michaela held commercial and general management positions for more than 20 years across the pharmaceutical and medical device industries and lectured in business at universities in Bolivia and Malaysia. She serves on the boards of Novartis Pharma GmbH Germany and Patient Focused Medicines Development (PFMD), as well as the Nomination Committee of the National Health Council in the US. She also co-authored the patient involvement chapter in Patient Involvement in Health Technology Assessment.

Judit Magos is a Clinical Operations Manager at Viatris Innovation with 15 years of international experience in clinical trials for drugs and medical devices. Her work spans multiple phases and therapeutic areas, including oncology and biosimilars, across both CRO and sponsor settings. She specializes in clinical operations and trial oversight, with a strong focus on collaboration, team engagement, and efficient study delivery. Judit is passionate about advancing clinical research to improve patient outcomes and also holds a degree in medical and health science translation.

Alessandra Grossi is Medical Operations Director at TransPerfect UK, with over 30 years of experience in the pharmaceutical industry. She has held leadership roles in Medical Information at local, regional and global levels, as well as positions in Medical Operations, Systems and Governance at Pfizer. Alessandra has led numerous system implementations, process harmonisation initiatives and innovation programmes. She is passionate about advancing Medical Information and Communication and is committed to driving its evolution through technology adoption and innovative practices, enhancing efficiency, compliance and the overall impact of medical affairs functions globally.

Michelle Bridenbaker is a toxicologist, critical care nurse, health communicator, and executive MBA with more than two decades of experience. She is passionate about bridging the gap between science and effective communication to ensure critical scientific and medical information reaches people around the world.

Lillian Auberson has more than 20 years of experience in global and regional medical affairs leadership roles across large pharmaceutical and rare disease companies, including Novartis, Roche, Actelion, Alexion, and argenx. She has developed strategic and innovative above-country operational frameworks in highly regulated settings, including medical information and patient support programs (PSPs). Together with industry peers, Lillian has helped elevate the strategic importance of medical information for customer engagement and co-founded both the annual Medical Information Conference in Europe and the Medical Information Leaders Europe (MILE) association. She is currently on assignment as Head of Quality Innovation and Operations at argenx.

Beatrice Omisakin, MPharm (Hons), is a healthcare and digital transformation leader with more than 24 years of experience in clinical pharmacy and global pharma, focused on applying AI, NLP, and automation to modernize medical information. As Head of Medical Information, EMEA at Takeda, she deployed AI/NLP analytics across 10 global brands and launched a medical information website serving more than 50 countries. Her previous roles at Novartis, Bristol Myers Squibb, Merck Sharp & Dohme, and the NHS in the UK span European and global medical information leadership. A GPhC-registered pharmacist, Beatrice is completing an MIT Professional Certificate in AI-Enabled Technology Leadership as part of the Chief Technology Officer Program.

Montse Bascompte is a pharmacist with an MSc in Pharmaceutical Industry and more than 25 years of experience in the pharmaceutical sector. She has led global regulatory portfolios, international teams, and transformation initiatives, combining deep regulatory expertise with a strong focus on business impact, collaboration, and people development.

Toni Burón Vidal is Global Head of Countries & Regions Patient Safety and Pharmacovigilance at Novartis, based in Switzerland. He brings extensive experience across patient safety, pharmacovigilance, and medical affairs, with previous senior roles at Novartis and Johnson & Johnson. A physician by training, Toni has worked across global, regional, and country-level organizations, giving him a broad perspective on how regulatory, safety, quality, and medical functions must evolve in an increasingly complex and data-driven environment. He brings particular insight into the future of pharmacovigilance, the strategic value of safety and regulatory functions, and the opportunities and responsibilities created by new technologies, including AI, in highly regulated healthcare settings.